Updated: July 2026
Published by Physician Growth Partners
The U.S. orthopedic market has cemented itself as one of the most promising sectors in physician services consolidation. Driven by an aging population, rising procedural volumes, the accelerating shift to outpatient settings, and a highly fragmented practice landscape, private equity firms, national health systems, and strategic consolidators are competing aggressively for quality orthopedic groups.
The combination of structural demographic tailwinds, strong margin profile, ancillary revenue upside, and buyer demand has created a market environment that independent orthopedic surgeons may be optimal for exploring a potential partnership.
However, orthopedic practice owners considering a sale should carefully assess potential partners, as transaction outcomes can vary widely and the market has produced both significant successes and notable failures.
The U.S. orthopedic market is experiencing rapid growth, driven largely by continued population aging. Census data indicates that nearly 80 million Americans will be over 65 by 2040, a steep increase in comparison to approximately 62 million today.1 Coupled with a shortage of physicians, the supply/demand imbalance in the orthopedic industry will continue to drive significant interest from outside investors looking to drive efficiency and benefits from economies of scale.
Musculoskeletal conditions are the leading driver of disability and one of the most prevalent chronic healthcare burdens in the United States. As the baby boomer cohort ages into the peak years for joint replacement, spine surgery, and sports medicine intervention, demand for orthopedic services is accelerating beyond what the existing supply of surgeons can absorb.
The shift to outpatient care is the defining structural trend reshaping orthopedic practice economics. Procedures once reserved for inpatient hospital stays, including knee, hip, and shoulder arthroplasty, are now routinely performed in ambulatory surgery centers (ASCs). UnitedHealth Group estimates this shift is saving the healthcare system $6 billion annually and is projected to save $70 billion over the next decade.2 For orthopedic practices with owned ASC interests, this migration is a significant and attractive growth lever.
Simultaneously, a persistent shortage of orthopedic surgeons, combined with escalating operational complexity, is making independent practice increasingly difficult to sustain without the infrastructure of a larger platform. Administrative burden, payor contracting leverage, implant cost management, and technology investment requirements are accelerating the calculus toward strategic partnership.
Integrated Ancillary Services – Advanced diagnostic imaging, physical therapy, durable medical equipment (DME), and other ancillaries that reduce referral leakage and improve revenue capture
Payor Mix & Contracting Strength – Diversified commercial payor mix, value-based care participation, and bundled payment capabilities that reduce regulatory and reimbursement risk
Operational Scalability – Management infrastructure and operational systems that enable a buyer to scale without re-platforming from scratch
The U.S. orthopedic sector has become a highly attractive target for private equity, health systems, and payer-aligned buyers. Strong procedure volumes, favorable reimbursement, ancillary revenue opportunities, demographic growth, and significant capital requirements for equipment and ASCs make the specialty well suited for scaled investment and sophisticated financial partners.
Private equity & private equity-backed platforms remain the dominant buyer within the space, although a number of alternative options exist for independent groups. Sponsors are attracted to the specialty’s high barriers to entry, procedure-based revenue model, and opportunity to develop ancillaries in-house.
National health systems and payer-aligned strategic buyers represent a second, increasingly active buyer category. The OrthoAlliance acquisition by SCA Health (Optum’s ASC subsidiary) is emblematic of a broader strategic shift: large integrated payers are acquiring orthopedic platforms to control the episode of care, capture ASC economics, and direct surgical volume away from high-cost hospital settings. Health systems, meanwhile, are acquiring independent orthopedic groups to anchor service lines, protect referral networks, and retain procedural revenue within their systems.
Lastly, the orthopedic space has seen scaled groups join together to form non-investment backed strategies, exemplified by the formation of PELTO Health. These strategies attempt to recreate the benefits of a large PE-backed MSO without the actual financial backing.
As the consolidation cycle matures, established platforms are executing add-on acquisition strategies to build geographic density, subspecialty depth, and the scale required for a premium platform exit.
It is essential to evaluate each prospective buyer’s track record, financial performance, and ability to deliver on its commitments. Thorough diligence should confirm that the buyer will preserve appropriate local autonomy while providing the resources, infrastructure, and capital needed to support growth.
Physicians must also carefully review and understand their employment, purchase, and operating agreements to ensure they are fully informed about the transaction terms and what the next phase of their careers will entail.
In orthopedics, transactions vary widely across the market, with some organizations struggling while others are achieving significant success.
The U.S. orthopedic M&A market is undergoing rapid consolidation as participants seek to build integrated, multi-site platforms with scale across geographies and subspecialties.
While incumbent platforms continue to build upon their established strategies, newer platforms have succeeded recently in landing partnerships with scaled practices. Evolve Orthopedic Partners and Sequel Orthopedics both recently closed upon partnerships involving multi-site practices with a full suite of ancillary services and vast geographic reach. With a fixed number of scaled independent groups remaining in the US, demand for marquee assets remains strong.
In recent years, PGP has advised on eight transactions across the orthopedic, pain management, and broader musculoskeletal (MSK) sectors, establishing the firm as one of the market’s most active healthcare M&A advisors. Most recently, in November 2025, PGP advised Fox Valley Orthopedics in their private equity partnership with Sequel Orthopedics, which private equity backed by InTandem Capital Partners.
PGP is also currently advising on several additional orthopedic transactions, providing the firm with real-time insight into evolving market trends, investor priorities, valuation dynamics, and emerging opportunities across the MSK landscape.
Below is a list of announced transaction that have been completed since January 2025.
| Date | Platform | Target | Commentary |
|---|---|---|---|
| Jan 2025 | OrthoIndiana | OrthoIndy, Tri-State Orthopaedics & Fort Wayne Orthopedics | Three-way independent practice merger forming one of the 10 largest independent orthopedic practices in the nation, with 160 physicians across ~40 statewide locations. |
| Feb 2025 | Growth Orthopedics | Orthopaedic Associates of Maine | 40+ provider group with 3 locations, one of the largest independent orthopedic practice in Maine and a new geographic entry point for Growth Orthopedics. |
| Mar 2025 | Orthopaedic Specialty Institute | Sea View Orthopaedics, Southern Orange County Orthopedic Group | Multi-group partnership, making OSI the largest independent orthopedic and neurosurgery provider in Southern California. Adds offices in Laguna Hills, Mission Viejo, and San Clemente. |
| Apr 2025 | Orthopaedic Solutions Management | Orlando Hand Surgical Associates | Subspecialty practice bringing hand and upper extremity surgical expertise to OSM’s Florida platform. |
| Jun 2025 | PELTO Health | Boston Orthopaedic and Spine | PELTO Health’s initial Northeast partnership, establishing an independent physician-led orthopedic and spine presence in the Boston market. |
| Jun 2025 | PELTO Health | Northwest Orthopaedic Specialists | Second PELTO Health partnership in June 2025, adding a Washington state orthopedic group and extending the platform’s reach to the Pacific Northwest. |
| Aug 2025 | Evolve Orthopedic Partners | OrthoNY | New MSO formed backed by Zenyth Partners. OrthoNY is an integrated, multi-site group and ASC operator serving Albany, Clifton Park, Glens Falls, Saratoga, and Schenectady. |
| Sep 2025 | OrthoLoneStar | Legacy Orthopedics | Regional development for OrthoLoneStar’s Texas network, extending the platform’s in-state geographic density. |
| Oct 2025 | Orthopaedic Solutions Management | Florida Orthopaedic Associates | Second Florida partnership for OSM in 2025, adding an established multi-physician group and further consolidating the platform’s presence across the state. |
| Oct 2025 | Emerge Ortho | Southeastern Orthopedic Specialists | Partnership adding Southeastern Orthopedic Specialists to Emerge Ortho’s North Carolina network, one of the largest independent orthopedic platforms in the Southeast. |
| Nov 2025 | Sequel Ortho | Fox Valley Orthopedics | Partnership marking Sequel Ortho’s entry into Illinois, adding a western Chicago suburbs orthopedic group to the platform and a new regional hub. (Advised by PGP) |
| Jan 2026 | Evolve Orthopedic Partners | Syracuse Orthopedics Specialists | Second Upstate New York partnership for Evolve, adding Syracuse Orthopedic Specialists. One of the largest independent orthopedic groups in the state. |
| Jan 2026 | Evolve Orthopedic Partners | New York Spine & Wellness Center | Third New York partnership for Evolve, adding interventional pain and spine services. |
| May 2026 | HOPCo | Orthopaedic Specialty Group | Southern Connecticut’s largest orthopedic practice with a vast geographic scope, joining HOPCo alongside a simultaneous merger with existing HOPCo partner OrthoConnecticut to form a statewide MSK platform. |
| May 2026 | HOPCo | OrthoConnecticut | ~50 provider group partnering with newly HOPCo-affiliated OSG to create the largest MSK platform in Connecticut. |
| Jun 2026 | Northeast Orthopaedic Alliance | South Shore Orthopedics | Tuck-in extending Northeast Orthopaedic Alliance’s Massachusetts footprint to the South Shore. |
Client Advised by PGP
Orthopedic practice owners are increasingly motivated to explore strategic partnerships by a convergence of operational pressures, competitive dynamics, and succession planning considerations.
Administrative complexity continues to escalate. Revenue cycle management for high-acuity orthopedic procedures, including bundled payments, implant cost management, prior authorization for spine and joint cases, and compliance with value-based care contracts requires infrastructure investment and specialized expertise that independent practices struggle to maintain efficiently. Larger organizations offer the ability to absorb these functions at scale, freeing physician time and resources for clinical care and practice growth.
Payer contracting = is increasingly difficult to sustain for independent practices. National and regional health systems, as well as PE-backed platforms with multi-market presence, negotiate from a position of strength that individual orthopedic groups cannot match. Joining a larger platform can materially improve the ability to maintain reimbursement rates, prove quality in those discussions, and reduce the risk of unfavorable payer renegotiations or network exclusions.
Implant cost management represents a significant and often underappreciated value driver in orthopedic practice economics. Larger platforms command purchasing leverage with implant manufacturers that can reduce per-case costs significantly, directly improving practice margin without any clinical change. For high-volume joint replacement and spine practices, the cumulative economic impact of platform-level supply and implant contracting is substantial.
Succession and estate planning are increasingly front-of-mind for a generation of senior orthopedic partners who built their practices over decades. A recapitalization or full sale provides liquidity, diversification, and estate planning flexibility that remaining independent does not. Many physician-owners also benefit from a meaningful equity rollover into the acquiring platform, allowing participation in the value created through the ongoing platform growth.
A handful of PE-backed orthopedic platforms are nearing the end of their typical hold periods, and the first wave of major second bite transactions has been exemplified by the OrthoAlliance exit to SCA Health. In combination with legacy platforms about to recapitalize with fresh capital, new market entrants have displayed a continued appetite for investment into the orthopedic space. The result is a market that strongly favors sellers. Demand for quality orthopedic practices is outpacing supply, and strategic acquirers, from national health systems to payer-aligned entities to PE-backed aggregators, are competing for a relatively small pool of assets that can demonstrate durable procedure volume, owned ancillary infrastructure, and a credible path to scalable growth. That competition is producing better terms, higher valuations, and more flexible deal structures than the orthopedic market has seen in years.
For founder-owned and independently operated orthopedic practices, the timing may be right to explore a transaction. Buyers who might have waited on the sidelines two years ago are now moving decisively, and the window of peak buyer competition is actively underway.
It is essential to carefully evaluate all potential partnership options, whether with private equity, an independent management services organization, or a hospital or health system. Each model offers distinct benefits, costs, and operational considerations, making it important to determine which structure best aligns with your group’s clinical, financial, and strategic priorities.
Because the performance and track records of potential partners can vary significantly, independent orthopedic groups should conduct the same level of diligence on prospective partners that those buyers conduct on them. Selecting the right partner can provide the resources and support needed for continued growth while preserving clinical autonomy and avoiding unnecessary interference with the practice of medicine.
No obligation. Completely confidential. Typically 30 minutes.
Sources & Citations
[1] https://www.astuteanalytica.com/industry-report/hip-replacement-market.
[2] UnitedHealth Group. “The Successful Shift of Joint Replacement Surgeries from Hospital Inpatient to Outpatient Setting,” June 2025. Estimated savings of $6B annually and $70B over the next decade.
[3] Spry / Forvis Mazars. 2026 Medicare Physician Fee Schedule Analysis. Net estimated -5% impact on orthopedic surgery reimbursement combining the conversion factor increase, -2.5% efficiency adjustment to work RVUs, and facility-based practice expense reductions. healthfmv.com, March 2026.
[4] DLA Piper. “A Growing State of Oversight: How States are Continuing to Reshape Healthcare Transactions and Private Equity Investment in Healthcare in 2025.” California, Massachusetts, Illinois, and New Mexico regulatory updates.
[5] Orthopedics This Week / SCA Health press release. “Optum’s ASC Unit Buys OrthoAlliance for $1.4 Billion,” January 2025. OrthoAlliance comprised 200+ physician partners across Ohio and Indiana at time of acquisition. ryortho.com.
Physician Growth Partners · This content is provided for informational purposes only and does not constitute legal, financial, or investment advice. All transaction data sourced as cited. © 2026 Physician Growth Advisors, LLC. All rights reserved.